Biocontrol, a UK-based developer of treatments to cure serious antibiotic-resistant infections, has raised Gbp500,000 in new funding. The Capital Fund led the transaction with a Gbp250,000 infusion. www.biocontrol.ltd.uk
Biocontrol, a UK-based developer of treatments to cure serious antibiotic-resistant infections, has raised Gbp500,000 in new funding. The Capital Fund led the transaction with a Gbp250,000 infusion. www.biocontrol.ltd.uk
Copyright PEI Media
Not for publication, email or dissemination